menu search

AXDX / Accelerate Diagnostics (AXDX) Reports Q4 Loss, Misses Revenue Estimates

Accelerate Diagnostics (AXDX) Reports Q4 Loss, Misses Revenue Estimates
Accelerate Diagnostics (AXDX) delivered earnings and revenue surprises of 12.50% and 0.93%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock? Read More
Posted: Mar 29 2023, 19:05
Author Name: Zacks Investment Research
Views: 110779

AXDX News  

Accelerate Diagnostics (AXDX) Moves 12.7% Higher: Will This Strength Last?

By Zacks Investment Research
October 3, 2023

Accelerate Diagnostics (AXDX) Moves 12.7% Higher: Will This Strength Last?

Accelerate Diagnostics (AXDX) witnessed a jump in share price last session on above-average trading volume. The latest trend in earnings estimate revi more_horizontal

Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates

By Zacks Investment Research
August 10, 2023

Accelerate Diagnostics (AXDX) Reports Q2 Loss, Misses Revenue Estimates

Accelerate Diagnostics (AXDX) came out with a quarterly loss of $2.36 per share versus the Zacks Consensus Estimate of a loss of $1.50. This compares more_horizontal

Is Accelerate Diagnostics (AXDX) Stock Outpacing Its Medical Peers This Year?

By Zacks Investment Research
June 29, 2023

Is Accelerate Diagnostics (AXDX) Stock Outpacing Its Medical Peers This Year?

Here is how Accelerate Diagnostics (AXDX) and BellRing Brands (BRBR) have performed compared to their sector so far this year. more_horizontal

Accelerate Diagnostics, Inc. (AXDX) Q1 2023 Earnings Call Transcript

By Seeking Alpha
May 11, 2023

Accelerate Diagnostics, Inc. (AXDX) Q1 2023 Earnings Call Transcript

Accelerate Diagnostics, Inc. (NASDAQ:AXDX ) Q1 2023 Earnings Conference Call May 11, 2023 4:30 PM ET Company Participants Laura Pierson - Investor Rel more_horizontal

Accelerate Diagnostics (AXDX) Reports Q1 Loss, Misses Revenue Estimates

By Zacks Investment Research
May 11, 2023

Accelerate Diagnostics (AXDX) Reports Q1 Loss, Misses Revenue Estimates

Accelerate Diagnostics (AXDX) came out with a quarterly loss of $0.17 per share in line with the Zacks Consensus Estimate. This compares to loss of $0 more_horizontal

Forget Bargain Hunting, Buy 5 Stocks With Rising P/E

By Zacks Investment Research
April 18, 2023

Forget Bargain Hunting, Buy 5 Stocks With Rising P/E

Tap five stocks with increasing P/E ratios to try out an out-of-the-box approach. These stocks include Disney (DIS), Casey's General Stores (CASY), Op more_horizontal

Accelerate Diagnostics (AXDX) Upgraded to Buy: What Does It Mean for the Stock?

By Zacks Investment Research
April 3, 2023

Accelerate Diagnostics (AXDX) Upgraded to Buy: What Does It Mean for the Stock?

Accelerate Diagnostics (AXDX) might move higher on growing optimism about its earnings prospects, which is reflected by its upgrade to a Zacks Rank #2 more_horizontal

Accelerate Diagnostics, Inc. (AXDX) Q4 2022 Earnings Call Transcript

By Seeking Alpha
March 29, 2023

Accelerate Diagnostics, Inc. (AXDX) Q4 2022 Earnings Call Transcript

Accelerate Diagnostics, Inc. (NASDAQ:AXDX ) Q4 2022 Earnings Conference Call March 29, 2023 4:30 PM ET Company Participants Laura Pierson - IR Jack Ph more_horizontal


Search within

Pages Search Results: